Rationale and design of POPular-TAVI: AntiPlatelet therapy for Patients undergoing Transcatheter Aortic Valve Implantation

American Heart Journal

Volumn 173, Issue , 2016, Pages 77-85

  Nijenhuis, Vincent Johan ^a   Bennaghmouch, Naoual ^a   Hassell, Mariella ^b   Baan, Jan ^b   Van Kuijk, Jan Peter ^a   Agostoni, Pierfrancesco ^a   Van 'T Hof, Arnoud ^c   Kievit, Peter C ^d   Veenstra, Leo ^e   Van Der Harst, Pim ^f   Van Den Heuvel, Ad F M ^f   Den Heijer, Peter ^g   Kelder, Johannes C ^a   Deneer, Vera H ^a   Van Der Kley, Frank ^h   Onorati, Francesco ⁱ   Collet, Jean Philippe ^j   Maisano, Francesco ^k   Latib, Azeem ^l   Huber, Kurt ^m   Stella, Pieter R ⁿ   Ten Berg, Jurrien M ^a   more..

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Department of Cardiology ^*  (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g AMPHIA HOSPITAL   (Netherlands)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY OF VERONA   (Italy)

^j PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^k UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^l VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^m WILHELMINEN HOSPITAL   (Austria)

ⁿ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ANTICOAGULATION; ARTICLE; BLEEDING; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HEART INFARCTION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MONOTHERAPY; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT DURATION; TREATMENT OUTCOME; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; AORTIC VALVE STENOSIS; CLINICAL TRIAL; COMBINATION DRUG THERAPY; DOSE RESPONSE; EUROPE; INCIDENCE; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROCEDURES; PROSPECTIVE STUDY; SURVIVAL RATE; THROMBOEMBOLISM; TIME FACTOR; TRENDS;

ADMINISTRATION, ORAL; AORTIC VALVE STENOSIS; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EUROPE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOEMBOLISM; TICLOPIDINE; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84960342473     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2015.11.008     Document Type: Article

References (45)

1. C.R. Smith, M.B. Leon, M.J. Mack, and et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 23 2011 2187 2198
2. M.B. Leon, C.R. Smith, M. Mack, and et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 17 2010 1597 1607
3. D.H. Adams, J.J. Popma, M.J. Reardon, and et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis N Engl J Med 370 19 2014 1790 1798
4. V.J. Nijenhuis, N. Bennaghmouch, J.-P. van Kuijk, and et al. Antithrombotic treatment in patients undergoing transcatheter aortic valve implantation (TAVI) Thromb Haemost 5 2015 113(4)
5. A. Vahanian, O. Alfieri, F. Andreotti, and et al. Guidelines on the management of valvular heart disease (version 2012) Eur Heart J 33 19 2012 2451 2496
6. D.R. Holmes, M.J. Mack, S. Kaul, and et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement J Am Coll Cardiol. Elsevier Inc 59 13 2012 1200 1254
7. J. Webb, J. Rodés-Cabau, S. Fremes, and et al. Transcatheter aortic valve implantation: A Canadian Cardiovascular Society position statement Can J Cardiol 28 5 2012 520 528
8. G.P. Ussia, M. Scarabelli, M. Mulè, and et al. Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation Am J Cardiol. Elsevier Inc 108 12 2011 1772 1776
9. J. Stępińska, K. Czerwińska, A. Witkowski, and et al. Risk factors for bleeding complications in patients undergoing transcatheter aortic valve implantation (TAVI) Cardiol J 20 2 2013 125 133
10. P. Poliacikova, J. Cockburn, A. de Belder, and et al. Antiplatelet and antithrombotic treatment after transcatheter aortic valve implantation - comparison of regimes J Invasive Cardiol 25 10 2013 544 548
11. E. Durand, D. Blanchard, S. Chassaing, and et al. Comparison of two antiplatelet therapy strategies in patients undergoing transcatheter aortic valve implantation Am J Cardiol 113 2 2014 355 360 [Durand, E., University Paris-Descartes, AP-HP, European Georges Pompidou Hospital, Departments of Cardiology and Cardiac Surgery, Paris, France]
12. B. Borz, E. Durand, M. Godin, and et al. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis Heart 99 12 2013 860 865
13. B.P. Halliday, R. Dworakowski, B. Brickham, and et al. Usefulness of periprocedural bleeding to predict outcome after transcatheter aortic valve implantation Am J Cardiol. Elsevier Inc 109 5 2012 724 728
14. N.M. Van Mieghem, R.-J. Nuis, A. Tzikas, and et al. Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation EuroIntervention 7 2 2011 184 191
15. G.P. Ussia, M. Barbanti, A.S. Petronio, and et al. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis Eur Heart J 33 8 2012 969 976
16. S.K. Kodali, M.R. Williams, C.R. Smith, and et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement N Engl J Med 366 18 2012 1686 1695
17. J. Rodés-Cabau, H.L. Dauerman, M.G. Cohen, and et al. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events 2013 J Am Coll Cardiol Elsevier Ltd
18. R. Mehran, S.V. Rao, D.L. Bhatt, and et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium Circulation 123 23 2011 2736 2747
19. A.P. Kappetein, S.J. Head, P. Généreux, and et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document J Am Coll Cardiol. Elsevier Inc 60 15 2012 1438 1454
20. J.L. Mega, E. Braunwald, S. Mohanavelu, and et al. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): A randomised, double-blind, phase II trial Lancet. Elsevier Ltd 374 9683 2009 29 38
21. M.S. Sabatine, E.M. Antman, P. Widimsky, and et al. Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): A randomised, double-blind, active-controlled, phase 2 trial Lancet. Elsevier Ltd 374 9692 2009 787 795
22. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 10 1993 673 682
23. P. Généreux, S.J. Head, N.M. Van Mieghem, and et al. Clinical outcomes after transcatheter aortic valve replacement using Valve Academic Research Consortium definitions: A weighted meta-analysis of 3,519 patients from 16 studies J Am Coll Cardiol 59 25 2012 2317 2326
24. P. Généreux, J.G. Webb, L.G. Svensson, and et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial J Am Coll Cardiol 60 12 2012 1043 1052
25. P.J. Khatri, J.G. Webb, J. Rodes-Cabau, and et al. Adverse effects associated with transcatheter aortic valve implantation: A meta-analysis of contemporary studies Ann Intern Med 158 1 2013 35 46
26. S. Yusuf, K.A.A. Fox, G. Tognoni, and et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 7 2001 494 502
27. M.S. Sabatine, C.P. Cannon, C.M. Gibson, and et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 12 2005 1179 1189
28. M.L. Hansen, R. Sørensen, M.T. Clausen, and et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation Arch Intern Med 170 16 2010 1433 1441
29. V.J. Nijenhuis, P.R. Stella, J. Baan, and et al. Antithrombotic therapy in patients undergoing TAVI: an overview of Dutch hospitals Neth Heart J 28 2013
30. C. Mérie, L. Køber, P. Skov Olsen, and et al. Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding JAMA 308 20 2012 2118 2125
31. S. Noble, A. Asgar, R. Cartier, and et al. Anatomo-pathological analysis after CoreValve Revalving system implantation EuroIntervention 5 1 2009 78 85
32. F. Al-Rashid, T.F.M. Konorza, B. Plicht, and et al. Transient increase in pressure gradients after termination of dual antiplatelet therapy in a patient after transfemoral aortic valve implantation Circ Cardiovasc Interv 5 2 2012 318 320
33. A. Latib, T. Naganuma, M. Abdel-Wahab, and et al. Treatment and clinical outcomes of transcatheter heart valve thrombosis Circ Cardiovasc Interv 8 4 2015 e001779
34. L. Nombela-Franco, J.G. Webb, P.P. de Jaegere, and et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation Circulation 126 25 2012 3041 3053
35. P. Kahlert, S.C. Knipp, M. Schlamann, and et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: A diffusion-weighted magnetic resonance imaging study Circulation 121 7 2010 870 878
36. R.R. Makkar, G.P. Fontana, H. Jilaihawi, and et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis N Engl J Med 366 18 2012 1696 1704
37. T. Pilgrim, S. Stortecky, F. Luterbacher, and et al. Transcatheter aortic valve implantation and bleeding: incidence, predictors and prognosis J Thromb Thrombolysis 35 4 2013 456 462
38. M.E.C.J. Hassell, D. Hildick-Smith, E. Durand, and et al. Antiplatelet therapy following transcatheter aortic valve implantation Heart 101 14 2015 1118 1125
39. A.G. Turpie, M. Gent, A. Laupacis, and et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement N Engl J Med 329 8 1993 524 529
40. A.L. Dans, S.J. Connolly, L. Wallentin, and et al. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial Circulation 127 5 2013 634 640
41. P.P. Karjalainen, P. Porela, A. Ylitalo, and et al. Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting Eur Heart J 28 6 2007 726 732
42. M. Lamberts, G.H. Gislason, J.B. Olesen, and et al. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention J Am Coll Cardiol 62 11 2013 981 989
43. W.J. Dewilde, T. Oirbans, F.W. Verheugt, and et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial Lancet 12 2013 1107 1115
44. R. Sørensen, M.L. Hansen, S.Z. Abildstrom, and et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: A retrospective analysis of nationwide registry data Lancet 374 9706 2009 1967 1974
45. U. Zeymer, R. Zahn, U. Gerckens, G. Richardt, H.-R. Figulla, and J. Denges Antithrombotic therapy after transfemoral aortic valve implantation (TAVI). Potential hazard of triple-therapy (abstr) Eur Heart J 32 2011 900